Accelerating development of genetic therapies for muscular dystrophies

The aim of MAGIC is to accelerate the development of gene therapies and genome editing strategies for muscular dystrophies by creating advanced humanized muscle models and innovative gene therapy approaches, ultimately improving the lives of individuals affected by these debilitating diseases.

Key Objectives

  1. Creating accurate humanized muscle models.
  2. Developing precise gene therapies and genome editing strategies.
  3. Engineering disease-specific muscle-on-chip devices.
  4. Assessing safety and efficacy of novel gene therapies.
  5. Exploring gene editing strategies for neuromuscular disorders.
  6. Facilitating translation and exploitation of project outputs.
  7. Ensuring patient perspectives remain central to the research.

See how MAGIC is working to reach these key objectives

Latest News